Experience with dalbavancin for cellulitis treatment in the emergency department

0

The recent development of novel, long-acting antibiotics has prompted exploration in the infectious disease literature of their use for cellulitis in the ED to decrease hospitalizations” Koziatek et al (2017).

Abstract:

Cellulitis is frequently encountered in the emergency department (ED) and is estimated to result in over 700,000 hospital admissions per year [1-3]. The recent development of novel, long-acting antibiotics has prompted exploration in the infectious disease literature of their use for cellulitis in the ED to decrease hospitalizations [4-6]. Dalbavancin is a semisynthetic lipoglycopeptide antibiotic with activity against gram-positive pathogens largely responsible for cellulitis, including methicillin-resistant Staphylococcus aureus (MRSA) [7].

Reference:

Koziatek, C., Mohan, S., Caspers, C., Swaminathan, A. and Swartz, J. (2017) Experience with dalbavancin for cellulitis in the emergency department and emergency observation unit. The American Journal of Emergency Medicine. November 15th. [epub ahead of print].

DOI: http://dx.doi.org/10.1016/j.ajem.2017.11.037

Thank you to our partners for supporting IVTEAM

Share.

Comments are closed.

Free Email Updates
Join 5.5K IVTEAM members. Subscribe now and be the first to receive all the latest free updates from IVTEAM!
100% Privacy. We don't spam.